CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B

Published:2024-04 Issue:7 Volume:10 Page:e28329
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Song Jingru,Liu Lu,Wang Zheng,Xie Dong,Azami Nisma Lena Bahaji^ORCID,Lu Lu,Huang Yanping,Ye Wei,Zhang Qin,Sun Mingyu^ORCID

Publisher

Elsevier BV

Reference63 articles.

1. The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification;Cao;Sci. Rep.,2021

2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet (London, England),2015

3. Epidemiology of hepatitis B virus infection and impact of vaccination on disease;Nelson;Clin. Liver Dis.,2016

4. Hepatitis B: epidemiology and prevention in developing countries;Franco;World J. Hepatol.,2012

5. Countdown to 2030: eliminating hepatitis B disease, China;Liu;Bull. World Health Organ.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive immune modulation mechanisms of Angong Niuhuang Wan in ischemic stroke: Insights from mass cytometry analysis;CNS Neuroscience & Therapeutics;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP